Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)

NCT07204327 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1136
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhongda Hospital